Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications

MAULDIN, SC / ACCESSWIRE / October 24, 2023 / Xcelerate, Inc. (OTCQB:XCRT) today announced the publication of its two utility patent applications, US 18/187,352 and US 18/189,441, by the United States Patent and Trademark Office (USPTO). The first review of the associated PCT applications, PCT/US2023/015755 and PCT/US2023/016194, has been received and addressed. As a result, these patent applications are currently undergoing the patent review process.

Foto: Accesswire

"These publications represent the continuation of Xcelerate's stated mission of utilizing non-medical engineering advancements and intellectual property that do not have immediate obvious applications to medical technology and applying them to clinical care. Different strategies can be employed to structure a patent that aligns with a company's broader IP strategy. In these filings Xcelerate has opted for broader claims with the flexibility to refine them as necessary. We believe that this approach will prove to be beneficial." said Mike O'Shea, Xcelerate's CEO. The co-inventors of these patent application are Xcelerate Advisory Board members Dr. Anja Glisovic and Dr. Dilan Ellegala.

ABOUT XCELERATE INC.

In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. In 2022, we expanded this business plan to include the marketing and sale of over-the-counter healthcare products. For more information visit the Company's website at www.xcelerate.global.

SAFE HARBOR

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.

SOURCE: Xcelerate, Inc.

View source version on accesswire.com:
https://www.accesswire.com/795771/xcelerate-inc-announces-publication- ...


The Xcelerate Stock at the time of publication of the news with a raise of 0,00 % to 0,050USD on Nasdaq OTC stock exchange (24. Oktober 2023, 02:10 Uhr).